RET signaling pathway and RET inhibitors in human cancer is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 98 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA228137
NCI NIH HHS
Grant: T32 CA247819
National Institutes of Health
Grant: 3P30CA012197-46S1
Cancer Center Support Grant
National Institutes of Health
Grant: 5T32CA247819-03
Translational Oncology Training Program
National Institutes of Health
Grant: 5R01CA228137-02
Roles of tGLI1 and microRNA Network in Breast Cancer Brain Metastasis
National Institutes of Health
Congressionally Directed Medical Research Programs
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Concurrent KRAS p.G12C mutation and ANK3::RET fusion in a patient with metastatic colorectal cancer: a case report
Additional file 1 of Concurrent KRAS p.G12C mutation and ANK3::RET fusion in a patient with metastatic colorectal cancer: a case report